|
(1'R,2S,4'S,5S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'E,24'S)-6-Cyclohexyl-24'-hydroxy-21'-(hydroxyimino)-5,11',13',22'-tetramethyl-2'-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6'-[3,7,19]trioxatetracyclo[ ;15.6.1.1.0]pentacosa[10,14,16,22]tetraen]-12'-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside
|
|
extended von Baeyer nomenclature: (10E,14E,16E,21Z)-(1R,4S,5’S,6R,6’S,8R,12S,13S,20R,21R,24S)-6’-cyclohexyl-24-hydroxy-21-hydroxyimino-5’,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2’-(tetrahydropyran)-12-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside
|
|
bridged fused ring systems nomenclature: (2aE,4E,8E,20Z)-(5’S,6S,6’S,7S,11R,13R,15S,17aR,20aR,20bS)-6’-cyclohexyl-3’,4’,5’,6,6’,7,10,11,14,15,17a,20,20a,20b-tetradecahydro-20b-hydroxy-20-hydroxyimino-5’,6,8,19-tetramethyl-17-oxospiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran]-7-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside
|
|
(5Z,25S)-25-cyclohexyl-4’-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)avermectin A1a
|
